In 2009, WADA released the first version of the Athlete Biological Passport (ABP) Operating Guidelines, which introduced a standardized approach to the profiling of individual athlete haematological variables (the ‘Haematological Module’).
The Steroidal Module, launched on January 1st, 2014, complements the Haematological Module and, like the Haematological Module, aims to identify potential athletes for further target testing in addition to assisting detection of anti-doping rule violations (ADRVs).
The Steroidal Module tests an athlete’s urine sample to observe unique steroidal variables such as testosterone, therefore making it a useful technique in spotting athlete abuse of Anabolic Androgenic Steroids.
At WADA’s Executive Committee Meeting on September 11, 2013, a new Technical Document (TD) on the Measurement and Reporting of Endogenous Anabolic Androgenic Steroids for Laboratories was approved. This Technical Document (TDEAAS2014) comes into force January 2014, and sets the stage for the introduction of the new ABP Steroidal Module.
Accordingly, ABP Operating Guidelines were revised by WADA to account for this new TD, which was a pre-condition for the launch of the Steroidal Module. The updated Operating Guidelines, available in the Download Center, were approved by WADA’s Executive Committee in November 2013 and take effect January 1st, 2014. They include modest changes to the mandatory documents on sample collection, sample transportation and results management, and provide guidance on the optimal way to implement this new module.